Visual Dysfunction in Diabetes. Questo articolo non è disponibile.
Lingua: inglese
Editore: Humana Press Inc., 2011
- Rilegato
- Nuovo

Da: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Venditore AbeBooks dal 9 ottobre 2009
Condizione: Nuovo
EUR 263,28
Descrizione dell’articolo da parte del venditore
This book helps readers understand the impact of vision impairment in people living with diabetes, rather than seeing diabetic retinopathy solely as a medical problem, and explores what we know and don't know about the ways diabetes affect the eye. Editor(s): Tombran-Tink, Joyce; Barnstable, Colin J.; Gardner, Thomas W. (Penn State University College of Medicine). Series: Ophthalmology Research. Num Pages: 394 pages, 8 black & white tables, biography. BIC Classification: MJGD; MJQ. Category: (P) Professional & Vocational. Dimension: 260 x 193 x 28. Weight in Grams: 935. . 2010. 2012. Hardback. . . . . Books ship from the US and Ireland.
Codice articolo V9781607611493
- Titolo
- Visual Dysfunction in Diabetes
- Autore
- . Ed(s): Tombran-Tink, Joyce; Barnstable, Colin J.; Gardner, Thomas W. (Penn State University College of Medicine)
- Editore
- Humana Press Inc.
- Anno di pubblicazione
- 2011
- Condizione
- New
- Rilegatura
- Rilegato
- Lingua
- inglese
- ISBN 10
- 160761149X
- ISBN 13
- 9781607611493
An exciting contribution to the field, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement is designed with two overriding objectives: to help readers understand the impact of vision impairment in people living daily with diabetes rather than considering diabetic retinopathy solely as a medical problem, and to explore what we know and don't know about the ways diabetes affect the eye. With the plethora of new information being generated, there are still a series of fundamental questions that must be addressed if effective treatments for diabetic retinopathy are to be found and applied. Developed by a renowned group of authorities, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers responses and context for a range of questions, such as: do metabolic factors beyond glucose contribute to vision-threatening diabetic retinopathy? If so, how do these lead to vision impairment? Is diabetic retinopathy a response to systemic metabolic abnormalities or are there unique ocular problems related to insulin resistance? What is the relationship between the neural, vascular, and inflammatory abnormalities in diabetic retinopathy? Do they represent a pathological cascade induced sequentially or simultaneous responses to one or more metabolic perturbations? The authors note that if we do not address these types of questions, it is possible that the long process of developing new therapeutic
s will target only one arm of the pathology and leave the retina open to damaging consequences of the others. State-of-the-art, comprehensive, and an invaluable addition the research and clinical literature, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers guidance and a significant step toward new scientific approaches that can lessen the devastating vision impairment associated with diabetes."Riassunto" può appartenere a un’altra edizione di questo titolo.
Dalla quarta di copertina
An exciting contribution to the field, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement is designed with two overriding objectives: to help readers understand the impact of vision impairment in people living daily with diabetes rather than considering diabetic retinopathy solely as a medical problem, and to explore what we know and don't know about the ways diabetes affect the eye. With the plethora of new information being generated, there are still a series of fundamental questions that must be addressed if effective treatments for diabetic retinopathy are to be found and applied. Developed by a renowned group of authorities, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers responses and context for a range of questions, such as: do metabolic factors beyond glucose contribute to vision-threatening diabetic retinopathy? If so, how do these lead to vision impairment? Is diabetic retinopathy a response to systemic metabolic abnormalities or are there unique ocular problems related to insulin resistance? What is the relationship between the neural, vascular, and inflammatory abnormalities in diabetic retinopathy? Do they represent a pathological cascade induced sequentially or simultaneous responses to one or more metabolic perturbations? The authors note that if we do not address these types of questions, it is possible that the long process of developing new therapeutic
s will target only one arm of the pathology and leave the retina open to damaging consequences of the others. State-of-the-art, comprehensive, and an invaluable addition the research and clinical literature, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement offers guidance and a significant step toward new scientific approaches that can lessen the devastating vision impairment associated with diabetes."Descrizione articolo" può appartenere a un’altra edizione di questo titolo.